141 related articles for article (PubMed ID: 35015099)
1. The spectrum of hemophagocytic lymphohistiocytosis: a retrospective study comparing adult macrophage activation syndrome to malignancy-associated hemophagocytic lymphohistiocytosis.
Good SD; Wade SD; Kyttaris VC
Rheumatol Int; 2022 Jul; 42(7):1247-1255. PubMed ID: 35015099
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin.
Sztajnbok F; Fonseca AR; Campos LR; Lino K; Rodrigues MCF; Silva RM; de Almeida RG; Perazzio SF; Carvalho MFF
Adv Rheumatol; 2024 Apr; 64(1):28. PubMed ID: 38627860
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP).
Sandler RD; Tattersall RS; Schoemans H; Greco R; Badoglio M; Labopin M; Alexander T; Kirgizov K; Rovira M; Saif M; Saccardi R; Delgado J; Peric Z; Koenecke C; Penack O; Basak G; Snowden JA
Front Immunol; 2020; 11():524. PubMed ID: 32296434
[No Abstract] [Full Text] [Related]
4. Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective.
Nguyen TTT; Kim YT; Jeong G; Jin M
Exp Mol Med; 2024 Mar; 56(3):559-569. PubMed ID: 38448692
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis.
Lee JC; Logan AC
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980725
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of macrophage activation syndrome and treatment progression.
Dong Y; Wang T; Wu H
Front Immunol; 2024; 15():1389710. PubMed ID: 38736876
[TBL] [Abstract][Full Text] [Related]
7. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
[TBL] [Abstract][Full Text] [Related]
8. Elevated monocyte HLA-DR in pediatric secondary hemophagocytic lymphohistiocytosis: a retrospective study.
Raimbault S; Monneret G; Gossez M; Venet F; Belot A; Zekre F; Remy S; Javouhey E
Front Immunol; 2023; 14():1286749. PubMed ID: 38077325
[TBL] [Abstract][Full Text] [Related]
9. Haemophagocytic lymphocytic histiocytosis/macrophage activation syndrome with acute inflammatory gastroenteritis.
Kolachana S; Malik A; Nanjudappa A; Iding J; Bhansali D; Haas CJ
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36002177
[TBL] [Abstract][Full Text] [Related]
10. Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature.
Aziz A; Castaneda EE; Ahmad N; Veerapalli H; Rockferry AG; Lankala CR; Hamid P
Cureus; 2021 Oct; 13(10):e18822. PubMed ID: 34804679
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Zhu L; Zhou D; Li L; Xie W; Tan Y; Ye X
Ann Hematol; 2023 Sep; 102(9):2301-2308. PubMed ID: 37266671
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of immune dysregulation in secondary hemophagocytic lymphohistiocytosis.
Wang Y; Yuan X; Wang T; Wei W; Wu S; Hou H
Virulence; 2024 Dec; 15(1):2342276. PubMed ID: 38629410
[TBL] [Abstract][Full Text] [Related]
13. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome.
Taylor ML; Hoyt KJ; Han J; Benson L; Case S; Chandler MT; Chang MH; Platt C; Cohen EM; Day-Lewis M; Dedeoglu F; Gorman M; Hausmann JS; Janssen E; Lee PY; Lo J; Priebe GP; Lo MS; Meidan E; Nigrovic PA; Roberts JE; Son MBF; Sundel RP; Alfieri M; Yeun JC; Shobiye DM; Degar B; Chang JC; Halyabar O; Hazen MM; Henderson LA
J Rheumatol; 2022 Sep; 49(9):1042-1051. PubMed ID: 35840156
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
Nakanuma S; Gabata R; Okazaki M; Seki A; Hosokawa K; Yokoyama T; Katano K; Sugita H; Tokoro T; Takada S; Makino I; Taniguchi T; Harada K; Yagi S
Transplant Proc; 2023 Oct; 55(8):1946-1950. PubMed ID: 37537076
[TBL] [Abstract][Full Text] [Related]
15. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW
Arthritis Rheumatol; 2023 Oct; 75(10):1714-1732. PubMed ID: 37486733
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature.
Chang Y; Shan X; Ge Y
Pediatr Rheumatol Online J; 2023 Sep; 21(1):106. PubMed ID: 37735702
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis-how common and how severe is it as a complication of malaria? Retrospective case series and review of the literature.
Orth HM; Wiemer D; Schneitler S; Schönfeld A; Holtfreter MC; Gliga S; Fuchs A; Pfäfflin F; Denkinger CM; Kalbitz S; Fritzsche C; Hübner MP; Trauth J; Jensen BO; Luedde T; Feldt T
Infection; 2024 Apr; 52(2):471-482. PubMed ID: 37875775
[TBL] [Abstract][Full Text] [Related]
18. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
Macaraeg M; Schulert GS
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690384
[TBL] [Abstract][Full Text] [Related]
19. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
Yin G; Man C; Liao S; Qiu H
Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
[TBL] [Abstract][Full Text] [Related]
20. The Decimating Army: Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Adult-Onset Still's Disease.
Agyeman WY; Waitimu S; Seffah KD; Allihien SM; Soleye S
Cureus; 2023 Aug; 15(8):e43875. PubMed ID: 37746424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
